| scholarly article | Q13442814 |
| P2093 | author name string | Bo Peng | |
| Hua Ye | |||
| Wei Qian | |||
| Jianying Zhang | |||
| Liping Dai | |||
| Pengfei Ren | |||
| Kaijuan Wang | |||
| Changqing Sun | |||
| P2860 | cites work | A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 |
| A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma | Q24676730 | ||
| The sentinel within: exploiting the immune system for cancer biomarkers | Q33221191 | ||
| Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma | Q33493776 | ||
| Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer. | Q33890172 | ||
| p53 Antibodies in the sera of patients with various types of cancer: a review | Q33892337 | ||
| Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. | Q34138916 | ||
| Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. | Q34612923 | ||
| Autoantibodies to tumor-associated antigens: reporters from the immune system | Q37118192 | ||
| Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. | Q37252915 | ||
| Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors | Q37724875 | ||
| Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. | Q40282641 | ||
| Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis | Q40511437 | ||
| Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation | Q41612390 | ||
| Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer | Q45263174 | ||
| Recursive partitioning as an approach to selection of immune markers for tumor diagnosis | Q46135231 | ||
| Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. | Q46821034 | ||
| Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients. | Q50535152 | ||
| Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. | Q51147084 | ||
| High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer | Q73863091 | ||
| Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein | Q73886871 | ||
| Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection | Q81752066 | ||
| Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer | Q83180901 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 663-668 | |
| P577 | publication date | 2012-12-05 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer | |
| P478 | volume | 5 |
| Q86521367 | Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer |
| Q57109579 | Autoantibodies as Potential Biomarkers in Breast Cancer |
| Q38107971 | Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC). |
| Q35753707 | Circulating antibodies to p16 protein-derived peptides in breast cancer |
| Q35123700 | Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens |
| Q89457572 | Establishment and validation of an immunodiagnostic model for prediction of breast cancer |
| Q37733163 | Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer |
| Q51105091 | Investigation of circulating antibodies to ANXA1 in breast cancer. |
| Q49419816 | Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality |
| Q37046496 | Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort |
| Q33594076 | Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens |
| Q45935803 | Study of circulating antibodies against CD25 and FOXP3 in breast cancer. |
| Q34037876 | Use of autoantibodies to detect the onset of breast cancer |
Search more.